Health Economics in HIV Disease
- 1 January 1999
- journal article
- review article
- Published by Springer Nature in PharmacoEconomics
- Vol. 15 (1) , 1-12
- https://doi.org/10.2165/00019053-199915001-00001
Abstract
No abstract availableKeywords
This publication has 54 references indexed in Scilit:
- German Health Economic Cost Evaluation on Oral Ganciclovir in Treating Cytomegalovirus RetinitisPharmacoEconomics, 1996
- Current Controversies in the Treatment of HIV Infection and AIDSPharmacoEconomics, 1996
- The Economic Costs of Caring for People with HIV Infection and AIDS in England and WalesPharmacoEconomics, 1996
- Lifetime hospitalization profiles for symptomatic, HIV-infected personsHealth Policy, 1996
- In-patient care for symptomatic, HIV-infected persons: A longitudinal study of hospitalizations, in-patient drug use, and related costsAIDS Care, 1995
- Cost Effectiveness of Antiviral Treatment with Zalcitabine plus Zidovudine for AIDS Patients with CD4+ Counts Less Than 300/??l in 5 European CountriesPharmacoEconomics, 1994
- Trends in hospital resource utilization by HIV-infected persons, January 1987–June 1990Health Policy, 1994
- The treatment and care costs of people with HIV infection or AIDS: development of a standardised cost framework for EuropeHealth Policy, 1993
- Treating AIDS: the economic issuesHealth Policy, 1988
- The acquired immune deficiency syndrome and epidemic of infection with human immunodeficiency virus: costs of care and prevention in an inner London district.BMJ, 1986